BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Cambridge’s PlaqueTec Names Former Dimension Therapeutics CEO as New Leader

  The life sciences leader will guide the company through its next growth phase and product launch in 2018.

  November 13, 2017

   · 

  4 min read
• Policy

  European Medicines Agency Grants Alnylam Accelerated Assessment of Patisiran for Patients with Hereditary ATTR (hATTR) Amyloidosis

  Alnylam intends to file a marketing authorization application (MAA) in the European Union (EU) at year-end 2017.

  November 13, 2017

   · 

  9 min read
• Genetown

  Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2017

  Enanta management will host a conference call at 4:30 p.m. ET to discuss these results and provide an update on Enanta’s business, including its research and development pipeline.

  November 13, 2017

   · 

  2 min read
• BioMidwest

  Canopy Biosciences’s New CRISPR Kits Simplify Gene Editing

  he CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene editing with the CRISPR-Cas9 system.

  November 13, 2017

   · 

  1 min read
• Drug Development

  Trovagene Announces Activation of First Clinical Trial Site in Phase Ib/II Acute Myeloid Leukemia Trial for PCM-075

  This trial will enroll subjects in the Phase Ib who have relapsed or have resistant disease to no more than three prior regimens.

  November 13, 2017

   · 

  7 min read
• Business

  Aerpio Reports Third Quarter 2017 Financial Results

  As of September 30, 2017, cash and cash equivalents totaled $24.8 million.

  November 13, 2017

   · 

  6 min read
• Biotech Beach

  EpicGenetics Release: FM/a Test Provides Objective Proof of Fibromyalgia for Gulf War Veterans; CHAMPVA Insurance Coverage for FM/a Test Now Available

  The FM/a Test is the first and only objective, FDA-compliant blood test to provide a definitive diagnosis for fibromyalgia.

  November 13, 2017

   · 

  6 min read
• Bio NC

  TransEnterix Announces Senhance U.S. Sale Agreement With Florida Hospital

  TransEnterix announced that Florida Hospital entered into an agreement to purchase the Company’s Senhance Surgical Robotic System.

  November 13, 2017

   · 

  4 min read
• Business

  Tenet Diagnostics Announces Appointments: Preeminent Scientist As Laboratory Director, and Pain and Opioid Prescribing Expert As Director of Provider Relations

  Tenet Chief Medical Officer Scott Howell, M.D., MPH &TM, CPE, emphasizes that these respected professionals advance Tenet’s mission to further empower physicians, collaborate with providers, and establish prescriber best practices.

  November 13, 2017

   · 

  2 min read
• Business

  MedX Health Corp. Announces the Addition of Two Renowned International Skin Cancer Specialists to Its Medical Scientific Advisory Board

  MedX Health Corp. is pleased to announce that Dr. Per Hall and Dr. Joe Walls, internationally renowned for their research on skin cancers and published authors of peer-reviewed research papers, have joined its Medical Scientific Advisory Board.

  November 13, 2017

   · 

  3 min read